Abstract. Sequence analysis of protein-coding human genes in human breast and colorectal cancer recently identified the KIAA1632 gene as a potential contributor to neoplastic processes in breast cancer. In the present study, we characterized the KIAA1632 gene by computational methods: detailed investigation of the genomic structure, protein prediction, identification of orthologs in other species and phylogenetic analysis. The human KIAA1632 gene was located within human genome sequence AC090355 and consists of 44 exons. KIAA1632 is located on chromosome 18q12.3-q21.1. These findings were determined by aligning the potential full-length transcript NM_020964 to the genomic sequence. The existing predicted gene model could be refined based on these alignments (using additional EST data). Protein sequence was predicted from the full-length transcript and possible orthologs in other species were identified. Using rigorous phylogenetic methods we were able to draw conclusions about the evolutionary history of these proteins. Comparison of the protein sequences of KIAA1632 and its orthologs revealed a shared 'signature motif'. This 'signature motif' was found in three well-characterized cancer antigens, raising the hypothesis of a common 'signature motif' for a certain group of cancer antigens.
Introduction
Cancer research has shed light on the molecular basis of malignancy. With the identification of the human genome sequence even more detailed identification of genetic alterations in cancer is possible (1) . One recent approach was the systematic analysis of 13023 genes in 11 breast and 11 colorectal cancers (2) . A group of 189 genes with significant genetic alterations was detected, the majority being not analysed previously in cancer. The identified genes are predicted to alter a broad range of cellular functions, e.g. transcription, adhesion and invasion. Many of these cancerassociated genes are well characterized but a minority have not been described in detail before. One interesting candidate is the KIAA1632 gene on chromosome 18q22.1. No detailed information on the genomic structure and possible proteins is available. However, a report on pericentric inversions on chromosome 18 involves the genomic region where supposedly KIAA1632 is located. These inversions are associated with psychiatric disorders and numerous genes are possible candidates for the pathomechanism of the observed condition (3) . In summary, KIAA1632 is an interesting candidate gene for the molecular analysis of breast cancer and it may even play an additional role in psychiatric disorders.
In this report we characterize the KIAA1632 gene and its orthologs in other species by bioinformatical methods. Coding region of human KIAA1632 (AK023817 and NM_020964) was found in the HUGO gene database (http://www.gene. ucl.ac.uk/nomenclature/). Using the sequence data from NM_020964 and available ESTs we refined the full-length KIAA1632 sequence. Genomic structure (intron and exon boundaries), expression data, functional relevant SNPs (single nucleotide polymorphisms), domain topology and comparative protein homology are discussed. Furthermore, we identified a 'signature motif' (deduced from KIAA1632 and its orthologs) that is also present in other cancer antigens and may lead to the identification of other cancer-associated genes. This is the first report on the characterization, phylogeny and the possible functional role of the KIAA1632 gene.
Materials and methods
Identification of a novel gene. Automatic annotation of the human genome has produced numerous entries but in many cases these entries are automated computational predictions and are therefore often incomplete. Human genome sequences, expressed sequence tags (ESTs) and uncharacterized cDNAs were analysed with BLASTN and MegaBLAST programs (http://www.ncbi.nlm.nih.gov/ BLAST) (4) (5) (6) . Available partial nucleotide sequence of human KIAA1632 was used as a query sequence (7, 8) . Additional databases were used for refinement of existing predictions.
Structural and chromosomal localization of the KIAA1632 gene. Exon-intron boundaries were determined by examining the consensus sequence of exon-intron junctions ['gt...ag' rule of intronic sequence, as described previously (9,10)] and the codon usage within the coding region. To refine the exonintron boundaries the existing cDNAs or ESTs (expressed sequence tags) were aligned to the genomic sequence (contig accession number AC090355) using SPIDEY (http://www. Table I . Exon-intron structure of human KIAA1632. 
ncbi. nlm.nih.gov/IEB/Research/Ostell/Spidey/). This revealed a different genomic structure of KIAA1632 as predicted by the automated computational analysis. These findings were then used to identify the human chromosomal localization of the genome clones in the Ensembl database (http://www. ensembl.org/) and subsequently the precise human chromosomal localization of KIAA1632 (11, 12 (19, 20) however we detected 108 possible domain-homologs, for a more detailed approach we used the domain homologs found in mammals. The comparative analysis of KIAA1632 in different species was performed using ClustalW (http://www.ebi.ac.uk/clustalw/) and the Ensembl (http://www.ensembl.org) database. Orthologs in other species were detected using PSI-BLAST (6) against the predicted amino acid sequence of KIAA1632. Phylogenetic analyses were performed using the MEGA3 package (21) and the DAMBE software (22) . Neighbour-joining (NJ) analysis, minimum evolution (ME) calculation, maximum parsimony (MP) and UPGMA analysis were performed with bootstrapping of 1000 replicates. Additionally TreePuzzle was used to generate maximum-likelihood distance matrices with 1000 quartet puzzling steps to assess branch support (23) .
Functional relevant SNP evaluation. To identify possible functional relevant SNPs (single nucleotide polymorphisms) that could disrupt ESE/ESS (exonic splicing enhancer/exonic splicing silencer) motifs (24, 25) we extracted coding SNP data from Ensembl (http://www.ensembl.org) and NCBI's SNPdb (http://www.ncbi.nlm.nih.gov). Using RESCUE-ESE (26) web server software (http://genes.mit.edu/cgi-bin/rescueese_new.pl) we analyzed 10 bp in either direction around each SNP.
Expression profiling. The expression profiles for normal human tissues were obtained from GeneAnnot (twelve normalized tissues were hybridized against Affymetrix GeneChips HG-U95B and HG-U95E with optimal annotation quality, see http:// bioinfo2.weizmann.ac.il/cgi-bin/geneannot/GA_search.pl? keyword_type=gene_symbol&keyword=KIAA1632) and from ArrayExpress (Affymetrix GeneChip HG-U133B). Furthermore, 'electronic Northern' analysis of NCBI's UniGene dataset was extracted from GeneCards (http://www.genecards.org).
Results
Human KIAA1632 gene. The data on KIAA1632 genomic structure in available databases (ENSEMBL, AltSpliceDB, etc.) shows a gene with 24-26 exons. The BLAST analysis however showed a longer transcript with more exons. According to our findings the full-length transcript is NM_020964 (confirming the HUGO entry) and the novel corresponding genomic structure shows a gene with 44 exons (for details see Table I ). KIAA1632 was localized to the genomic region of chromosome 18q12.3-q21.1 due to the mapping of the human genome clone AC090355 to this region. Boundaries of exon-intron junctions were determined through alignment of ESTs to the genomic sequence and through observation of consensus sequences at exon-intron junctions. Human KIAA1632 cDNA consists of a 7737-bp coding region, a 4860-bp 3'-UTR and it encodes a 2579-aa KIAA1632 protein. Comparative proteomics of KIAA1632 orthologs and phylogeny. Data mining revealed putative orthologs of human KIAA1632 in different species. Orthologs were found in mammals, fish, flies and worms. These proteins were analyzed with MEME (27) which showed three distinct motifs. These motifs are depicted in Fig. 1 , whereas motifs 'A' and 'B' are only found in mammals. The distribution of motifs across different species is shown in Fig. 2 . Phylogenetic analysis was carried out using multiple phylogenetic models. The best supported phylogenic tree is shown in Fig. 3 .
Possible functions of KIAA1632. Analysis with the PRATT algorithm identified a common motif for human KIAA1632 and its orthologs in other species. The consensus pattern for this domain is:
. Using this pattern for a search in the PROSITE database showed several proteins containing similar domains. Interestingly three other cancer antigens were detected with this approach. Cancer antigens were tumor antigen se2-2 (28), NY-REN-58 (29) and CNG1 (30) . The complete list of detected proteins can be found at http://www.halama. org/KIAA1632pratt.htm. The majority of mammalian domain homologs detected with PRATT are involved in cell-cell interaction and adhesion.
SNP analysis. From the data of three available SNPs (rs1893523, rs3744996 and rs3744998) in the genomic region of KIAA1632 we identified three as functionally relevant, i.e. one of the available alleles disrupted an existing exonic splicing enhancer or the SNP resulted in a non-synonymous amino acid change. Sequences and available allele frequencies for rs3744996 are shown in Fig. 4 . An amino acid change from Valin to Alanin was reported at amino acid residue 343 for rs1893523. An identical amino acid change was also reported for rs3744998 at residue 1059.
Expression profiles of human KIAA1632. The investigation of available microarray experiments and the results of the 'virtual Northern blot' showed a predominant expression of Unambiguously aligned amino acids were analysed by distance (Protdist + NJ), maximum parsimony (MP) minimal evolution (ME) and clustering likelihood (UPGMA: unweighted pair-group method using arithmetic averages) methods. The tree shown is the NJ distance topology. Numbers at the nodes represent the percent of bootstrap replicates in support of each group for the respective method (the small box in the upper left shows the order of presented numbers: NJ, neighbour-joining; MP, maximum parsimony; ME, minimal evolution and UPGMA). The numbers for the quartet puzzling steps (as generated with TreePuzzle) confirm the presented model (data not shown KIAA1632 in the thymus, the central nervous system, muscle cells (heart and skeletal muscle), liver and prostate tissue and in kidney and lung tissue. Literature research showed that KIAA1632 is also found in breast and cervical cancer. Additional information was obtained from the GNF SymAtlas (http://symatlas.gnf.org/SymAtlas/), showing an elevated expression in cells of the immune system (e.g. CD4 + , CD8 + and natural killer cells).
Discussion
The human KIAA1632 gene, consisting of 44 exons is located at human chromosome 18q12.3-q21.1. We analyzed the human KIAA1632 gene in this study by refinement of the genomic structure and characterization of possible phylogenetic relations to orthologous proteins in other species. To reveal the genomic structure of human KIAA1632 we identified the complete coding sequence. KIAA1632 genomic sequence was determined by assembling the full-length transcript (accession number NM_020964) to the genomic region (genome sequence AC090355). The putative protein sequence of KIAA1632 showed orthologs in other species, all belonging to the phylogenetic group of bilateria. Based on the phylogenetic findings the protein originated one billion years ago. This finding suggests a functional importance for higher eukaryotic species.
In silico expression analyses revealed that human KIA1632 mRNA is expressed in a variety of tissues: in cells of the immune system, thymus, the central nervous system, muscle cells (heart and skeletal muscle), liver and prostate tissue, kidney and lung tissue and in breast and cervical cancer.
Analysis of the amino acid sequence of the putative KIAA1632 protein revealed no known domains. Interestingly the comparative analysis revealed a common 'signature motif' found in all KIAA1632 homologous proteins. A database search detected this 'signature motif' in two well-known cancer antigens: tumor antigen se2-2 (Nephrocystin-6) and NY-REN-58 antigen (renal cancer antigen). Antibodies against se2-2/Nephrocystin-6 are present in sera from patients with cutaneous T-cell lymphomas (31) and NY-REN-58 is an antigen recognized by autologous antibodies in patients with renal-cell carcinoma (29).
Furthermore, we detected this 'signature motif' in the 'Rod photoreceptor cGMP-gated channel subunit α' (CNG1) protein, a protein of a new class of cancer antigens in melanoma: novel photoreceptor proteins that are responsible for visual transduction and its regulation (30) .
This raises the question: is there a common 'signature motif' for a certain type of tumor antigen? What possible function in cancer have those other (mammalian) proteins which have this motif? Subsequently KIAA1632 could also be an immunogenic cancer antigen. The function of the motif-related domain is unknown, but the relative abundance of proteins involved in cell-cell interaction or adhesion hints to a possible structural role.
In summary, this is the first report on comparative integromics on KIAA1632 and its orthologs, revealing clues to a 'signature motif' of a cancer antigen domain. 
